Answers are grounded in this paper and cite their sources.
Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) is a rare disorder of water homeostasis caused by constitutive activation of the renal vasopressin V2 receptor and may closely mimic syndrome of inappropriate antidiuresis (SIAD). Recognition in infancy is challenging because severe hyponatremia may remain clinically silent and conventional biochemical findings may overlap with other disorders of water balance. We report the clinical, biochemical, and molecular characterization of a 7-month-old male infant with severe hypotonic hyponatremia incidentally identified during evaluation for bronchiolitis, which persisted after resolution of the acute respiratory illness. Serum sodium was 112 mmol/L and serum osmolality was 231 mOsm/kg (calculated), with preserved renal and hepatic function. Adrenal insufficiency was excluded by ACTH stimulation testing, while a low copeptin concentration (2 pmol/L) supported appropriately suppressed vasopressin secretion. Whole-exome sequencing identified the pathogenic activating hemizygous AVPR2 c.409C>T, p.(Arg137Cys) variant, confirming NSIAD, together with a pathogenic heterozygous ACVRL1 c.270C>A, p.(Cys90*) variant associated with hereditary hemorrhagic telangiectasia. The co-occurrence of these two pathogenic variants is clinically relevant for surveillance and genetic counselling but is not proposed as a mechanistic explanation of the water-balance disorder. To the best of our knowledge, this represents the first reported case of genetically confirmed NSIAD in Romania and the first documented coexistence of these two pathogenic variants in a single patient. Although mechanistically unrelated, their coexistence highlights the clinical relevance of comprehensive genetic testing in identifying additional actionable diagnoses. Fluid restriction and oral urea were followed by an improvement in serum sodium to 130 mmol/L. This case illustrates the diagnostic value of integrating copeptin assessment with genomic testing in severe unexplained hypotonic hyponatremia in infancy, and highlights the need for independent surveillance of concomitant pathogenic findings identified by broad genomic testing.
No takes yet. Share an insight, caveat, or question.
Vasiliu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: